REGN
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: May 04, 2026 03:23:01 PM (GMT)
REGN: The current live price is 377.1, with no percentage change indicated from the previous price.
Support and Resistance Levels The pivot point is at 377.1, with support levels at 377.1 (three times) and resistance levels also at 377.1 (three times).
Indicators RSI is currently at 100 and has remained constant, indicating strong bullish momentum. The ATR is at 0, suggesting low volatility. The Parabolic SAR is at 377.1, indicating a consistent trend.
Market Sentiment As the current price equals the pivot of 377.1, and indicators suggest strong buying momentum, a bullish scenario is likely.
About (regn) Regeneron Pharmaceuticals, Inc.
Company Background
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a leading biotechnology company headquartered in Tarrytown, New York. Founded in 1988, Regeneron specializes in discovering, developing, and commercializing innovative medicines for the treatment of serious diseases. The company is renowned for its commitment to scientific excellence and has established a robust pipeline of biologics and small-molecule drugs. Regeneron's core areas of focus include ophthalmology, oncology, immunology, and cardiovascular diseases, fostering a diversified portfolio that addresses significant unmet medical needs.
Market Position
Regeneron is recognized as one of the prominent players in the biotech industry, with a strong market presence driven by its advanced research capabilities and successful product launches. The company's flagship products, such as EYLEA (aflibercept) for eye diseases and Dupixent (dupilumab) for various allergic and inflammatory conditions, have significantly contributed to its revenue streams. Regeneron's competitive advantage lies in its proprietary VelociSuite® technology platform, which accelerates the discovery of new therapeutic candidates, ensuring the company remains at the forefront of innovation in the pharmaceutical sector.
Key Financial Highlights
Regeneron's financial performance reflects its strong market position and effective operational strategies. As of the most recent fiscal year, the company reported impressive revenue growth, driven by the robust sales of its existing therapeutics and the advancement of its pipeline products. The company has consistently delivered positive earnings results, translating to a strong return on investment for shareholders. Furthermore, Regeneron maintains a solid balance sheet, providing it with the flexibility to invest in research and development, explore strategic partnerships, and pursue acquisitions that enhance its therapeutic offerings.
Industry Highlights
The biotechnology industry continues to evolve, with Regeneron playing a pivotal role in addressing critical healthcare challenges. The global demand for innovative therapies is increasing, driven by an aging population and the rising prevalence of chronic diseases. As Regeneron expands its pipeline and enhances its R&D capabilities, it is poised to capitalize on emerging market trends and maintain its leadership position within the biotechnology landscape.
How to Buy or Trade Regeneron Pharmaceuticals, Inc. Stock (REGN) with AvaTrade
Trading or investing in Regeneron Pharmaceuticals, Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol REGN, which represents Regeneron Pharmaceuticals, Inc.. Before placing a trade, review the live Regeneron Pharmaceuticals, Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Regeneron Pharmaceuticals, Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Regeneron Pharmaceuticals, Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
